201 related articles for article (PubMed ID: 26650752)
1. Therapeutic goals in patients with pheochromocytoma: a guide to perioperative management.
Azadeh N; Ramakrishna H; Bhatia NL; Charles JC; Mookadam F
Ir J Med Sci; 2016 Feb; 185(1):43-9. PubMed ID: 26650752
[TBL] [Abstract][Full Text] [Related]
2. Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma.
Brunaud L; Boutami M; Nguyen-Thi PL; Finnerty B; Germain A; Weryha G; Fahey TJ; Mirallie E; Bresler L; Zarnegar R
Surgery; 2014 Dec; 156(6):1410-7; discussion1417-8. PubMed ID: 25456922
[TBL] [Abstract][Full Text] [Related]
3. Preoperative pharmacological management of phaeochromocytoma.
van der Horst-Schrivers AN; Kerstens MN; Wolffenbuttel BH
Neth J Med; 2006 Sep; 64(8):290-5. PubMed ID: 16990692
[TBL] [Abstract][Full Text] [Related]
4. The perioperative management of a patient with complex single ventricle physiology and pheochromocytoma.
Sparks JW; Seefelder C; Shamberger RC; McGowan FX
Anesth Analg; 2005 Apr; 100(4):972-975. PubMed ID: 15781508
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Management of Pheochromocytoma and Paraganglioma.
Fang F; Ding L; He Q; Liu M
Front Endocrinol (Lausanne); 2020; 11():586795. PubMed ID: 33117294
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma: an approach to antihypertensive management.
Bravo EL
Ann N Y Acad Sci; 2002 Sep; 970():1-10. PubMed ID: 12381537
[TBL] [Abstract][Full Text] [Related]
7. Degree of catecholamine hypersecretion is the most important determinant of intra-operative hemodynamic outcomes in pheochromocytoma.
Kramer CK; Leitão CB; Azevedo MJ; Canani LH; Maia AL; Czepielewski M; Paggi A; Rodrigues TC; Silveiro SP; Friedman R; Gross JL
J Endocrinol Invest; 2009 Mar; 32(3):234-7. PubMed ID: 19542740
[TBL] [Abstract][Full Text] [Related]
8. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.
Patel D; Phay JE; Yen TWF; Dickson PV; Wang TS; Garcia R; Yang AD; Kim LT; Solórzano CC
Ann Surg Oncol; 2020 May; 27(5):1338-1347. PubMed ID: 32112213
[TBL] [Abstract][Full Text] [Related]
9. Abandonment of intravenous volume expansion after preoperative receipt of α-blockers in patients with adrenal pheochromocytoma was not an independent risk factor for intraoperative hemodynamic instability.
Yan KW; Tian XF; Wu YN; Cai M; Guo MT
Front Endocrinol (Lausanne); 2023; 14():1131564. PubMed ID: 37152944
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of the perioperative factors contributing to the hemodynamic changes during surgery in ten patients with pheochromocytoma].
Konno D; Nishino R; Ejima Y; Ohnishi E; Sato K; Kurosawa S
Masui; 2013 Apr; 62(4):421-5. PubMed ID: 23697193
[TBL] [Abstract][Full Text] [Related]
11. [Perioperative management of paragangliomas and pheochromocytomas].
Fermandois M; Altamirano J; Rojas F; Román C; Pinto I
Medwave; 2020 Mar; 20(2):e7830. PubMed ID: 32191683
[TBL] [Abstract][Full Text] [Related]
12. Anesthetic management of pheochromocytoma with potent long acting alpha- and beta-adrenergic receptor blockers.
Miyazaki M; Yokono S
Med J Osaka Univ; 1980 Mar; 30(3-4):65-9. PubMed ID: 6106153
[No Abstract] [Full Text] [Related]
13. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Buitenwerf E; Osinga TE; Timmers HJLM; Lenders JWM; Feelders RA; Eekhoff EMW; Haak HR; Corssmit EPM; Bisschop PHLT; Valk GD; Veldman RG; Dullaart RPF; Links TP; Voogd MF; Wietasch GJKG; Kerstens MN
J Clin Endocrinol Metab; 2020 Jul; 105(7):2381-91. PubMed ID: 31714582
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades.
Livingstone M; Duttchen K; Thompson J; Sunderani Z; Hawboldt G; Sarah Rose M; Pasieka J
Ann Surg Oncol; 2015 Dec; 22(13):4175-80. PubMed ID: 25822781
[TBL] [Abstract][Full Text] [Related]
15. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.
Tauzin-Fin P; Sesay M; Gosse P; Ballanger P
Br J Anaesth; 2004 Apr; 92(4):512-7. PubMed ID: 14766711
[TBL] [Abstract][Full Text] [Related]
16. [Pre- and postoperative antihypertensive treatment with calcium antagonist in pheochromocytoma].
Colson P; Ribstein J; Chaptal PA; Mimran A; Roquefeuil B
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1123-5. PubMed ID: 2124450
[TBL] [Abstract][Full Text] [Related]
17. Preoperative management of the pheochromocytoma patient.
Pacak K
J Clin Endocrinol Metab; 2007 Nov; 92(11):4069-79. PubMed ID: 17989126
[TBL] [Abstract][Full Text] [Related]
18. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.
Agrawal R; Mishra SK; Bhatia E; Mishra A; Chand G; Agarwal G; Agarwal A; Verma AK
World J Surg; 2014 Mar; 38(3):716-23. PubMed ID: 24233658
[TBL] [Abstract][Full Text] [Related]
19. [Preoperative management in pheochromocytoma (author's transl)].
Yu TL
Zhonghua Wai Ke Za Zhi; 1979; 17(4):264-6. PubMed ID: 45366
[No Abstract] [Full Text] [Related]
20. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin.
Lord MS; Augoustides JG
J Cardiothorac Vasc Anesth; 2012 Jun; 26(3):526-31. PubMed ID: 22361482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
